Renaissance Group »

Catalyst Pharmaceutical Partners shares owned by Renaissance Group

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Renaissance Group from 13F filings

Historical chart of Renaissance Group investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Renaissance Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Renaissance Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.0M 356k 19.70
2025-06-30 $7.1M 329k 21.70
2025-03-31 $6.1M 252k 24.25
2024-12-31 $4.2M 203k 20.87

More positions owned by Renaissance Group

Applovin Corp Com Cl A (APP)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Arista Networks Com Shs (ANET)
Emcor (EME)
Meta Platforms Cl A (META)
Apple (AAPL)
Comfort Systems USA (FIX)
Amphenol Corp Cl A (APH)
Netflix (NFLX)
Kla Corp Com New (KLAC)
Applied Materials (AMAT)
Amazon (AMZN)
Cadence Design Systems (CDNS)

View all positions for Renaissance Group

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners